8VC GP I’s BiomX PHGE Stock Holding History

8VC GP I’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,717	Closed	-$111K	–	3
2024 Q3	$111K	Hold	5,717	–	–	0.15%	3
2024 Q2	$365K	Hold	5,717	–	–	0.45%	3
2024 Q1	$489K	Hold	5,717	–	–	0.62%	3
2023 Q4	$304K	Buy	+5,717	New	+$360K	0.31%	3

Other funds holding PHGE

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Allostery Investments Stamford, Connecticut $7.85M AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

8VC GP I's PHGE Position: Q4 2024 in Review

8VC GP I sold out of BiomX (PHGE) in Q4 2024, closing a stake of 5,717 shares — an estimated $111K sold.

8VC GP I first reported a position in PHGE in Q4 2023 and held it in 4 quarters. The position peaked at $489K in Q1 2024. 17 funds tracked by Wall St. Rank hold PHGE as of Q4 2024.

8VC GP I reported no remaining BiomX position as of Q4 2024 after selling out during the quarter.
8VC GP I sold 5,717 BiomX shares in Q4 2024, an estimated $111K.
8VC GP I first reported a position in BiomX in Q4 2023 and held it in 4 quarters.
8VC GP I's BiomX position peaked at $489K in Q1 2024.
17 funds tracked by Wall St. Rank held BiomX as of Q4 2024.

Based on 8VC GP I's 13F filing for Q4 2024, filed 6 Feb 2025.